TScan Therapeutics Announces Closing of Upsized Public Offering
Go back to TScan Therapeutics Announces Closing of Upsized Public Offering| Dreyfus/Laurel Funds Trust Dreyfus Core Value Fund Class I (NASDAQ: TCRX) | Delayed: 0.67 --0 (-0%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $0.67 | 52 Week High | $26.80 | |||
| Open | $0.67 | 52 Week Low | $23.00 | |||
| Day High | $0.67 | P/E | N/A | |||
| Day Low | $0.67 | EPS | $0.00 | |||
| Volume | 36 | |||||
